Grau, G., Brunet-Mas, E., Llovet, L., Pedregal, P., Villoria, A., Melcarne, L., . . . Calvet, X. (2023). Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital.
Citación estilo ChicagoGrau, G., et al. Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients With Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital. 2023.
Cita MLAGrau, G., et al. Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients With Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital. 2023.